查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1495512

丙吡胺市場：按形式、作用機制、適應症和分銷管道分類 - 全球預測 2024-2030

Disopyramide Market by Form (Capsule, Solution), Action Mechanism (Antagonist, Inhibitor), Indication, Distribution Channel - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年丙吡胺市場規模為2.4582億美元，預計2024年將達2.5728億美元，2030年將達3.4291億美元，複合年成長率為4.86%。

丙吡胺是一種主要用於治療某些嚴重心律不整（心律不整）的藥物，例如心房顫動。它的作用是恢復正常心律並維持規律、穩定的心率，被歸類為 IA 類抗心律不整藥物。擴大使用的因素包括人口老化，更容易患心血管疾病，診斷技術的進步，可以及時發現心律不整，以及對預防醫學的興趣增加。然而，丙吡胺也有缺點，包括潛在的副作用，如口乾、便秘、閉尿症和心臟衰竭。由於可能與其他藥物發生交互作用或使現有疾病惡化，因此必須仔細監測其使用。此外，丙吡胺的市場機會包括改進配方以最大程度地減少副作用、開拓與其他心血管藥物的聯合治療以提高療效以及提高對心臟病治療的認知和可及性，這包括新興市場的擴張。此外，對心律不整分子機制的持續研究可能會帶來使用上的創新和新替代療法的開發。

主要市場統計
基準年[2023] 2.4582億美元
預測年份 [2024] 2.5728億美元
預測年份 [2030] 34291萬美元
複合年成長率（%） 4.86%

區域洞察

美國是一個由完善的醫療保健系統和心臟病高盛行率驅動的重要市場，需要持續獲得丙吡胺等治療方法。患者受益於 FDA 嚴格監督強化的系統，該系統推動了持續的藥物創新，包括上市後安全測試。相較之下，加拿大的全民健保系統在政府對醫療保健領域的大量投資的支持下，確保了人們廣泛獲得此類藥物。歐盟丙吡胺的市場動態各不相同，因為各成員國的醫療保健系統和法規差異很大。然而，歐洲藥品管理局 (EMA) 提供了一個集中的法律規範，可以簡化整個歐洲藥品的核准和分配。這種泛歐洲方法有助於穩定不同國家的需求和消費行為。在亞太地區，醫療保健成熟度的差異創造了多樣化的市場環境。中國正在透過迅速加強醫療保健框架和促進本地藥品生產來提高丙吡胺的可及性。日本以其最先進的醫療保健系統而聞名，憑藉高度的醫療可靠性和持續創新，保持穩定的市場需求。同時，印度的學名藥產業正在蓬勃發展，支持政府改善醫療保健的努力，滿足對負擔得起的藥品的強勁需求。

FPNV定位矩陣

FPNV 定位矩陣對於評估丙吡胺市場供應商的定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對丙吡胺市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他關鍵指標。此外，該分析還提供了對該領域競爭性質的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對丙吡胺市場當前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人口老化加劇，更容易罹患心血管疾病
      • 加強公共衛生工作和心臟病檢測
    • 抑制因素
      • 與丙吡胺相關的產品召回和安全問題
    • 機會
      • 藥物輸送系統的技術進步提高了給藥的便利性
      • 開發與其他心血管藥物的聯合治療以提高療效
    • 任務
      • 與丙吡胺相關的副作用
  • 市場區隔分析
    • 形式：膠囊是首選，因為方便且能夠長期維持穩定的藥物濃度
    • 分銷管道：考慮安全、便利、可近性，擴大線上分銷
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章丙吡胺市場：依形式

  • 膠囊
  • 解決方案

第7章 丙吡胺市場行動機制

  • 對手
  • 抑制劑

第8章丙吡胺市場依適應症分類

  • 心律不整
  • 心室預激
  • 心室心搏過速

第9章丙吡胺市場：依通路

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第10章 美洲丙吡胺市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太丙吡胺市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲丙吡胺市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 細胞動力學報告了最新 REDWOOD-HCM 隊列研究的有希望的結果
  • 戰略分析和建議

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-5D693B46BFFF

[183 Pages Report] The Disopyramide Market size was estimated at USD 245.82 million in 2023 and expected to reach USD 257.28 million in 2024, at a CAGR 4.86% to reach USD 342.91 million by 2030.

Disopyramide is a medication primarily used to treat certain types of serious irregular heartbeats (arrhythmias) such as atrial fibrillation. It functions by restoring normal heart rhythms and maintaining a regular, steady heartbeat, classified as a Class IA antiarrhythmic agent. Factors contributing to its expanded use include an aging population prone to cardiovascular diseases, advancements in diagnostic technologies enabling timely detection of arrhythmias, and a growing emphasis on preventive healthcare. However, disopyramide does have disadvantages, including potential side effects such as dry mouth, constipation, urinary retention, and heart failure. Due to its interaction with other medications and potential exacerbation of existing conditions, its usage must be carefully monitored. Furthermore, the market opportunities for disopyramide include formulation improvements to minimize side effects, the development of combination therapies with other cardiovascular drugs to enhance efficacy, and expansion in emerging markets where there is increasing awareness and access to treatments for heart conditions. Moreover, ongoing research into the molecular mechanisms of arrhythmias could lead to innovations in disopyramide usage or the development of novel therapeutic alternatives.

KEY MARKET STATISTICS
Base Year [2023] USD 245.82 million
Estimated Year [2024] USD 257.28 million
Forecast Year [2030] USD 342.91 million
CAGR (%) 4.86%

Regional Insights

In the Americas, the United States remains a pivotal market, fueled by a well-established healthcare system and a substantial prevalence of cardiac disorders, which necessitates ongoing access to treatments like disopyramide. Patients benefit from a system enhanced by stringent FDA oversight that promotes continuous pharmaceutical innovation, including safety studies post-commercialization. In contrast, Canada's universal healthcare system ensures wide accessibility to such medications, supported by substantial governmental healthcare investments. The market dynamics for disopyramide in the EU vary, as healthcare systems and regulations differ significantly across member countries. However, the European Medicines Agency (EMA) provides a centralized regulatory framework that can streamline approvals and distributions of medications across Europe. This pan-European approach helps stabilize demand and consumer behavior across different countries. In the Asia Pacific, disparities in healthcare maturity create diverse market landscapes. China is rapidly enhancing its healthcare framework and boosting local drug production, increasing accessibility to disopyramide. Japan, known for its cutting-edge healthcare system, maintains stable market demand through high trust in healthcare practices and continuous innovation. Meanwhile, India leverages its robust generic drug industry to meet significant demands for affordable medications, supported by governmental efforts to enhance healthcare reach.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Disopyramide Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Growing aging population prone to cardiovascular diseases
      • Increased public health initiatives and screening for heart diseases
    • Market Restraints
      • Product recall and safety concerns associated with disopyramide
    • Market Opportunities
      • Technological advancements in drug delivery systems to increase the ease of administration
      • Development of combination therapies with other cardiovascular drugs to enhance efficacy
    • Market Challenges
      • Side effects associated with disopyramide
  • Market Segmentation Analysis
    • Form: Preference towards capsule due to its convenience and the ability to maintain steady drug levels over time
    • Distribution Channel: Expansion of online distribution due to its safety, convenience, and accessibility
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Disopyramide Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Disopyramide Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Cytokinetics Reports Encouraging Outcomes from Latest REDWOOD-HCM Cohort Study

Cytokinetics announced positive preliminary results from the third cohort of its REDWOOD-HCM (Hypertrophic Cardiomyopathy) study, which assessed the efficacy and safety of their leading drug candidate, disopyramide. The study aims to explore alternative therapies for individuals living with hypertrophic cardiomyopathy, a condition characterized by the thickening of the heart muscle which can lead to various cardiac symptoms and complications. [Published On: 2022-02-01]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Disopyramide Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Disopyramide Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca plc, Dr. Reddy's Labratories Inc., Merck & Co., Inc., Novartis Group, Pfizer Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., The Bristol-Myers Squibb Company, and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Disopyramide Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Form
    • Capsule
      • Extended-Release Capsules
      • Immediate-Release Capsules
    • Solution
  • Action Mechanism
    • Antagonist
    • Inhibitor
  • Indication
    • Cardiac Dysrhythmias
    • Ventricular Pre-excitation
    • Ventricular Tachycardia
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing aging population prone to cardiovascular diseases
      • 5.1.1.2. Increased public health initiatives and screening for heart diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Product recall and safety concerns associated with disopyramide
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in drug delivery systems to increase the ease of administration
      • 5.1.3.2. Development of combination therapies with other cardiovascular drugs to enhance efficacy
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects associated with disopyramide
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Form: Preference towards capsule due to its convenience and the ability to maintain steady drug levels over time
    • 5.2.2. Distribution Channel: Expansion of online distribution due to its safety, convenience, and accessibility
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Disopyramide Market, by Form

  • 6.1. Introduction
  • 6.2. Capsule
  • 6.3. Solution

7. Disopyramide Market, by Action Mechanism

  • 7.1. Introduction
  • 7.2. Antagonist
  • 7.3. Inhibitor

8. Disopyramide Market, by Indication

  • 8.1. Introduction
  • 8.2. Cardiac Dysrhythmias
  • 8.3. Ventricular Pre-excitation
  • 8.4. Ventricular Tachycardia

9. Disopyramide Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Online Pharmacies
  • 9.4. Retail Pharmacies

10. Americas Disopyramide Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Disopyramide Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Disopyramide Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Cytokinetics Reports Encouraging Outcomes from Latest REDWOOD-HCM Cohort Study
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. DISOPYRAMIDE MARKET RESEARCH PROCESS
  • FIGURE 2. DISOPYRAMIDE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DISOPYRAMIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DISOPYRAMIDE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL DISOPYRAMIDE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. DISOPYRAMIDE MARKET DYNAMICS
  • FIGURE 7. GLOBAL DISOPYRAMIDE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL DISOPYRAMIDE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. DISOPYRAMIDE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. DISOPYRAMIDE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DISOPYRAMIDE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DISOPYRAMIDE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL DISOPYRAMIDE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL DISOPYRAMIDE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL DISOPYRAMIDE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL DISOPYRAMIDE MARKET SIZE, BY CAPSULE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL DISOPYRAMIDE MARKET SIZE, BY CAPSULE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL DISOPYRAMIDE MARKET SIZE, BY EXTENDED-RELEASE CAPSULES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL DISOPYRAMIDE MARKET SIZE, BY EXTENDED-RELEASE CAPSULES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL DISOPYRAMIDE MARKET SIZE, BY IMMEDIATE-RELEASE CAPSULES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL DISOPYRAMIDE MARKET SIZE, BY IMMEDIATE-RELEASE CAPSULES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL DISOPYRAMIDE MARKET SIZE, BY SOLUTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL DISOPYRAMIDE MARKET SIZE, BY SOLUTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL DISOPYRAMIDE MARKET SIZE, BY ANTAGONIST, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL DISOPYRAMIDE MARKET SIZE, BY ANTAGONIST, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL DISOPYRAMIDE MARKET SIZE, BY INHIBITOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL DISOPYRAMIDE MARKET SIZE, BY INHIBITOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL DISOPYRAMIDE MARKET SIZE, BY CARDIAC DYSRHYTHMIAS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL DISOPYRAMIDE MARKET SIZE, BY CARDIAC DYSRHYTHMIAS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL DISOPYRAMIDE MARKET SIZE, BY VENTRICULAR PRE-EXCITATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL DISOPYRAMIDE MARKET SIZE, BY VENTRICULAR PRE-EXCITATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL DISOPYRAMIDE MARKET SIZE, BY VENTRICULAR TACHYCARDIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL DISOPYRAMIDE MARKET SIZE, BY VENTRICULAR TACHYCARDIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL DISOPYRAMIDE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL DISOPYRAMIDE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL DISOPYRAMIDE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL DISOPYRAMIDE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL DISOPYRAMIDE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL DISOPYRAMIDE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 73. CANADA DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 74. CANADA DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 85. MEXICO DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 86. MEXICO DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 87. MEXICO DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 88. MEXICO DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 91. MEXICO DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 92. MEXICO DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 95. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 96. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 97. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 98. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 118. AUSTRALIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 120. AUSTRALIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 122. AUSTRALIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 124. AUSTRALIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 126. AUSTRALIA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 127. CHINA DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 128. CHINA DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 129. CHINA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 130. CHINA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 131. CHINA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 132. CHINA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 133. CHINA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 134. CHINA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 135. CHINA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 136. CHINA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 137. INDIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 138. INDIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 139. INDIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 140. INDIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 141. INDIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 142. INDIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 143. INDIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 144. INDIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 145. INDIA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 146. INDIA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 147. INDONESIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 148. INDONESIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 149. INDONESIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 150. INDONESIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 151. INDONESIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 152. INDONESIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 153. INDONESIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 154. INDONESIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 155. INDONESIA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 156. INDONESIA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 157. JAPAN DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 158. JAPAN DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 159. JAPAN DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 160. JAPAN DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 161. JAPAN DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 162. JAPAN DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 163. JAPAN DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 164. JAPAN DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 165. JAPAN DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 166. JAPAN DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 167. MALAYSIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 168. MALAYSIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 169. MALAYSIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 170. MALAYSIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 171. MALAYSIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 172. MALAYSIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 173. MALAYSIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 174. MALAYSIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 175. MALAYSIA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 176. MALAYSIA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 178. PHILIPPINES DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 180. PHILIPPINES DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 182. PHILIPPINES DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 184. PHILIPPINES DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 186. PHILIPPINES DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 187. SINGAPORE DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 188. SINGAPORE DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 189. SINGAPORE DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 190. SINGAPORE DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 191. SINGAPORE DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 192. SINGAPORE DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 193. SINGAPORE DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 194. SINGAPORE DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 195. SINGAPORE DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 196. SINGAPORE DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 197. SOUTH KOREA DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 198. SOUTH KOREA DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 200. SOUTH KOREA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 202. SOUTH KOREA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 204. SOUTH KOREA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 206. SOUTH KOREA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 207. TAIWAN DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 208. TAIWAN DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 209. TAIWAN DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 210. TAIWAN DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 211. TAIWAN DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 212. TAIWAN DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 213. TAIWAN DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 214. TAIWAN DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 215. TAIWAN DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 216. TAIWAN DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 217. THAILAND DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 218. THAILAND DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 219. THAILAND DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 220. THAILAND DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 221. THAILAND DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 222. THAILAND DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 223. THAILAND DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 224. THAILAND DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 225. THAILAND DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 226. THAILAND DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 227. VIETNAM DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 228. VIETNAM DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 229. VIETNAM DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 230. VIETNAM DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 231. VIETNAM DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 232. VIETNAM DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 233. VIETNAM DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 234. VIETNAM DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 235. VIETNAM DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 236. VIETNAM DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 249. DENMARK DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 250. DENMARK DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 251. DENMARK DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 252. DENMARK DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 253. DENMARK DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 254. DENMARK DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 255. DENMARK DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 256. DENMARK DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 257. DENMARK DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 258. DENMARK DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 259. EGYPT DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 260. EGYPT DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 261. EGYPT DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 262. EGYPT DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 263. EGYPT DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 264. EGYPT DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 265. EGYPT DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 266. EGYPT DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 267. EGYPT DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 268. EGYPT DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 269. FINLAND DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 270. FINLAND DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 271. FINLAND DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 272. FINLAND DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 273. FINLAND DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 274. FINLAND DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 275. FINLAND DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 276. FINLAND DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 277. FINLAND DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 278. FINLAND DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 279. FRANCE DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 280. FRANCE DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 281. FRANCE DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 282. FRANCE DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 283. FRANCE DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 284. FRANCE DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 285. FRANCE DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 286. FRANCE DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 287. FRANCE DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 288. FRANCE DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 289. GERMANY DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 290. GERMANY DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 291. GERMANY DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 292. GERMANY DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 293. GERMANY DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 294. GERMANY DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 295. GERMANY DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 296. GERMANY DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 297. GERMANY DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 298. GERMANY DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 299. ISRAEL DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 300. ISRAEL DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 301. ISRAEL DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 302. ISRAEL DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 303. ISRAEL DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 304. ISRAEL DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 305. ISRAEL DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 306. ISRAEL DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 307. ISRAEL DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 308. ISRAEL DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 309. ITALY DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 310. ITALY DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 311. ITALY DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 312. ITALY DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 313. ITALY DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 314. ITALY DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 315. ITALY DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 316. ITALY DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 317. ITALY DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 318. ITALY DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 319. NETHERLANDS DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 320. NETHERLANDS DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 321. NETHERLANDS DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 322. NETHERLANDS DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 323. NETHERLANDS DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 324. NETHERLANDS DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 326. NETHERLANDS DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 328. NETHERLANDS DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 329. NIGERIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 330. NIGERIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 331. NIGERIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 332. NIGERIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 333. NIGERIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 334. NIGERIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 335. NIGERIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 336. NIGERIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 337. NIGERIA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 338. NIGERIA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 339. NORWAY DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 340. NORWAY DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 341. NORWAY DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 342. NORWAY DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 343. NORWAY DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 344. NORWAY DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 345. NORWAY DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 346. NORWAY DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 347. NORWAY DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 348. NORWAY DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 349. POLAND DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 350. POLAND DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 351. POLAND DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 352. POLAND DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 353. POLAND DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 354. POLAND DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 355. POLAND DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 356. POLAND DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 357. POLAND DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 358. POLAND DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 359. QATAR DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 360. QATAR DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 361. QATAR DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 362. QATAR DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 363. QATAR DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 364. QATAR DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 365. QATAR DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 366. QATAR DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 367. QATAR DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 368. QATAR DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 369. RUSSIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 370. RUSSIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 371. RUSSIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
  • TABLE 372. RUSSIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
  • TABLE 373. RUSSIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 374. RUSSIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 375. RUSSIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 376. RUSSIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 377. RUSSIA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 378. RUSSIA DISOPYRAMIDE MARKET SIZE, BY DISTRIB